

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.40297524 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.40297524 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.40297524 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.40297524 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.40297524 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.40297524 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 6.15569704 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.01708945 |
| 9 | response to peptidoglycan (GO:0032494) | 5.93325945 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.03022595 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.03022595 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.88251689 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.86751934 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.79666930 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.65216829 |
| 16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.58990922 |
| 17 | response to host immune response (GO:0052572) | 4.58990922 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 4.54070926 |
| 19 | * respiratory burst (GO:0045730) | 4.52279912 |
| 20 | granulocyte activation (GO:0036230) | 4.49838382 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.49165437 |
| 22 | detection of bacterium (GO:0016045) | 4.48902637 |
| 23 | neutrophil activation (GO:0042119) | 4.41871880 |
| 24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.38371023 |
| 25 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.32250387 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 4.21022056 |
| 27 | leukocyte aggregation (GO:0070486) | 4.16153367 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.13618647 |
| 29 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08084029 |
| 30 | response to host (GO:0075136) | 4.08084029 |
| 31 | response to host defenses (GO:0052200) | 4.08084029 |
| 32 | detection of biotic stimulus (GO:0009595) | 4.02145345 |
| 33 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.99152750 |
| 34 | positive regulation of mast cell degranulation (GO:0043306) | 3.99152750 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.85272513 |
| 36 | positive regulation of mast cell activation (GO:0033005) | 3.83995818 |
| 37 | microglial cell activation (GO:0001774) | 3.81645777 |
| 38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.80908700 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.79646148 |
| 40 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.70215549 |
| 41 | natural killer cell mediated immunity (GO:0002228) | 3.70215549 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66563650 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.61342393 |
| 44 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58545446 |
| 45 | macrophage activation (GO:0042116) | 3.57097301 |
| 46 | B cell mediated immunity (GO:0019724) | 3.56643193 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.56137273 |
| 48 | positive regulation of interferon-beta production (GO:0032728) | 3.55684236 |
| 49 | * hydrogen peroxide biosynthetic process (GO:0050665) | 3.54228977 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 3.52403190 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.51471583 |
| 52 | cellular response to type I interferon (GO:0071357) | 3.51471583 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.51207668 |
| 54 | response to type I interferon (GO:0034340) | 3.50133130 |
| 55 | * superoxide anion generation (GO:0042554) | 3.49901150 |
| 56 | response to muramyl dipeptide (GO:0032495) | 3.48921508 |
| 57 | cellular extravasation (GO:0045123) | 3.48030995 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.46452570 |
| 59 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42829130 |
| 60 | leukocyte mediated cytotoxicity (GO:0001909) | 3.41725759 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.40361042 |
| 62 | defense response to protozoan (GO:0042832) | 3.40013016 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.39186646 |
| 64 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37511121 |
| 65 | positive regulation of antigen processing and presentation (GO:0002579) | 3.35120067 |
| 66 | neutrophil mediated immunity (GO:0002446) | 3.34350038 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33214861 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32085693 |
| 69 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.31051498 |
| 70 | regulation of tolerance induction (GO:0002643) | 3.28845456 |
| 71 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.27652774 |
| 72 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.27295527 |
| 73 | regulation of mononuclear cell migration (GO:0071675) | 3.27234482 |
| 74 | regulation of chemokine biosynthetic process (GO:0045073) | 3.25844857 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 3.25270469 |
| 76 | positive regulation of leukocyte degranulation (GO:0043302) | 3.24137742 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.23567174 |
| 78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.22643074 |
| 79 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21947470 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21002467 |
| 81 | cellular response to zinc ion (GO:0071294) | 3.19719108 |
| 82 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.19241196 |
| 83 | * reactive oxygen species biosynthetic process (GO:1903409) | 3.18304202 |
| 84 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.18223905 |
| 85 | regulation of T cell tolerance induction (GO:0002664) | 3.18046923 |
| 86 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.16607299 |
| 87 | negative regulation of interleukin-17 production (GO:0032700) | 3.15726125 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14661376 |
| 89 | T-helper 1 type immune response (GO:0042088) | 3.14617073 |
| 90 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13255741 |
| 91 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.12877083 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12875136 |
| 93 | neutrophil chemotaxis (GO:0030593) | 3.11858632 |
| 94 | regulation of leukocyte degranulation (GO:0043300) | 3.11779026 |
| 95 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10550356 |
| 96 | glycosphingolipid catabolic process (GO:0046479) | 3.10213279 |
| 97 | positive regulation of heat generation (GO:0031652) | 3.09399255 |
| 98 | lymphocyte chemotaxis (GO:0048247) | 3.08212433 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 3.06277863 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04385190 |
| 101 | neutrophil migration (GO:1990266) | 3.03121813 |
| 102 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.02476911 |
| 103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99673311 |
| 104 | amino sugar catabolic process (GO:0046348) | 2.97827119 |
| 105 | I-kappaB phosphorylation (GO:0007252) | 2.97095610 |
| 106 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.95218127 |
| 107 | regulation of fever generation (GO:0031620) | 2.95174811 |
| 108 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.95090749 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.94298897 |
| 110 | T cell migration (GO:0072678) | 2.93832599 |
| 111 | response to protozoan (GO:0001562) | 2.93737038 |
| 112 | myeloid leukocyte activation (GO:0002274) | 2.93489238 |
| 113 | response to interferon-alpha (GO:0035455) | 2.92502062 |
| 114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.92315471 |
| 115 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.91224760 |
| 116 | negative regulation of growth of symbiont in host (GO:0044130) | 2.90283685 |
| 117 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.90283685 |
| 118 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.90283685 |
| 119 | regulation of growth of symbiont in host (GO:0044126) | 2.90283685 |
| 120 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.90050587 |
| 121 | regulation of antigen processing and presentation (GO:0002577) | 2.89028250 |
| 122 | regulation of macrophage cytokine production (GO:0010935) | 2.89006486 |
| 123 | positive regulation of macrophage cytokine production (GO:0060907) | 2.88702851 |
| 124 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87578643 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.87078672 |
| 126 | detection of other organism (GO:0098543) | 2.86995625 |
| 127 | oligosaccharide catabolic process (GO:0009313) | 2.86589783 |
| 128 | lymphocyte mediated immunity (GO:0002449) | 2.86101910 |
| 129 | regulation of cholesterol storage (GO:0010885) | 2.85393461 |
| 130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83313701 |
| 131 | germinal center formation (GO:0002467) | 2.82820136 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.78974751 |
| 133 | regulation of B cell differentiation (GO:0045577) | 2.78016488 |
| 134 | glycolipid catabolic process (GO:0019377) | 2.77633821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.22170912 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.06134659 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.49809538 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.76717746 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.36631225 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.15177834 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.07090794 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96321625 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.86916204 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53943283 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.45378098 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.39485430 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01174006 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94195205 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.92674818 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79463819 |
| 17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79184742 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51492551 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41943135 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30339351 |
| 21 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.30131165 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29549930 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.05543283 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98746974 |
| 25 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.88144179 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87581080 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80776427 |
| 28 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80339485 |
| 29 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75031671 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74371976 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.72612546 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.72304619 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71658270 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68369039 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66838404 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66342610 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61688071 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59928452 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55070499 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53574655 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.47679505 |
| 42 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.46601759 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.43190792 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43021409 |
| 45 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42768330 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40217157 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.37626646 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37606486 |
| 49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32584901 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.31558263 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27977242 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24952941 |
| 53 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24725837 |
| 54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24471237 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24119707 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21544642 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20321127 |
| 58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20282224 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16204693 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15667246 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13257062 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12314765 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11903657 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10533015 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10137707 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09744601 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09276806 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05211888 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97749151 |
| 70 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97020121 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93035088 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86744698 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86680876 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85252532 |
| 75 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83884942 |
| 76 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83143977 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83126005 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83126005 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82668703 |
| 80 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81165974 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80231327 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79452885 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78417826 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78217789 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75547886 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75029732 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74963131 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.74116702 |
| 89 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73458625 |
| 90 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72188715 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.71471395 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70649198 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70348656 |
| 94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69923854 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 0.69921537 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.69706441 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69301517 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.68492275 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.68332838 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.68272558 |
| 101 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.67834671 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67700209 |
| 103 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.67398612 |
| 104 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67167546 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67035775 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64601050 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64461874 |
| 108 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62141771 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62109815 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59118677 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59016397 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.58174712 |
| 113 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57496166 |
| 114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.56380576 |
| 115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.56380576 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.56379844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.65965615 |
| 2 | MP0003436_decreased_susceptibility_to | 4.20136403 |
| 3 | MP0009785_altered_susceptibility_to | 3.96527852 |
| 4 | MP0003303_peritoneal_inflammation | 3.95372200 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.57075717 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.50477981 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.32791999 |
| 8 | * MP0005025_abnormal_response_to | 3.13048900 |
| 9 | MP0006082_CNS_inflammation | 3.08714713 |
| 10 | MP0003724_increased_susceptibility_to | 3.07193568 |
| 11 | MP0005058_abnormal_lysosome_morphology | 3.03450623 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.79723291 |
| 13 | * MP0005387_immune_system_phenotype | 2.74650764 |
| 14 | * MP0001790_abnormal_immune_system | 2.74650764 |
| 15 | MP0000685_abnormal_immune_system | 2.68395278 |
| 16 | MP0001800_abnormal_humoral_immune | 2.66932757 |
| 17 | MP0002723_abnormal_immune_serum | 2.58773743 |
| 18 | MP0004510_myositis | 2.45504233 |
| 19 | MP0005671_abnormal_response_to | 2.44177395 |
| 20 | * MP0001819_abnormal_immune_cell | 2.33006504 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.30510041 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.28653745 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.18549668 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.01304590 |
| 25 | * MP0001845_abnormal_inflammatory_respons | 1.97975781 |
| 26 | MP0009764_decreased_sensitivity_to | 1.97390496 |
| 27 | MP0002405_respiratory_system_inflammati | 1.96265057 |
| 28 | MP0004947_skin_inflammation | 1.92130686 |
| 29 | MP0001853_heart_inflammation | 1.89772666 |
| 30 | MP0003075_altered_response_to | 1.87526486 |
| 31 | MP0009278_abnormal_bone_marrow | 1.86203238 |
| 32 | MP0000343_altered_response_to | 1.82285162 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.76485906 |
| 34 | MP0008469_abnormal_protein_level | 1.73716872 |
| 35 | MP0000716_abnormal_immune_system | 1.63584073 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.61381536 |
| 37 | MP0002006_tumorigenesis | 1.59855382 |
| 38 | * MP0003448_altered_tumor_morphology | 1.58944659 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.58677312 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.55066605 |
| 41 | MP0000604_amyloidosis | 1.54027808 |
| 42 | MP0005310_abnormal_salivary_gland | 1.48890079 |
| 43 | MP0002398_abnormal_bone_marrow | 1.48743104 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.44930590 |
| 45 | MP0005166_decreased_susceptibility_to | 1.41653150 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.39586829 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.39127373 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.31242938 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.31242938 |
| 50 | MP0002429_abnormal_blood_cell | 1.29765819 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.29291150 |
| 52 | MP0003690_abnormal_glial_cell | 1.28419050 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.26614292 |
| 54 | MP0009840_abnormal_foam_cell | 1.25674850 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.23090615 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.22995313 |
| 57 | MP0003828_pulmonary_edema | 1.15413220 |
| 58 | MP0005164_abnormal_response_to | 1.15065500 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.13972865 |
| 60 | MP0002722_abnormal_immune_system | 1.13056991 |
| 61 | MP0001851_eye_inflammation | 1.12456440 |
| 62 | MP0003329_amyloid_beta_deposits | 1.12206268 |
| 63 | MP0003186_abnormal_redox_activity | 1.11986402 |
| 64 | * MP0000858_altered_metastatic_potential | 1.11467097 |
| 65 | MP0008260_abnormal_autophagy | 1.09781421 |
| 66 | MP0005076_abnormal_cell_differentiation | 1.09428934 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.08999737 |
| 68 | MP0005390_skeleton_phenotype | 1.07432647 |
| 69 | MP0009763_increased_sensitivity_to | 1.02342931 |
| 70 | MP0002933_joint_inflammation | 0.99771173 |
| 71 | MP0003866_abnormal_defecation | 0.99468333 |
| 72 | MP0002132_abnormal_respiratory_system | 0.98099605 |
| 73 | MP0008004_abnormal_stomach_pH | 0.97341099 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 0.94665719 |
| 75 | MP0010307_abnormal_tumor_latency | 0.93873578 |
| 76 | MP0003195_calcinosis | 0.84609235 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.84345466 |
| 78 | MP0000249_abnormal_blood_vessel | 0.80790816 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.80662164 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.76856943 |
| 81 | MP0004381_abnormal_hair_follicle | 0.76362411 |
| 82 | MP0000371_diluted_coat_color | 0.75059297 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.73602397 |
| 84 | MP0000015_abnormal_ear_pigmentation | 0.72439649 |
| 85 | MP0006054_spinal_hemorrhage | 0.72305286 |
| 86 | MP0004883_abnormal_blood_vessel | 0.72055380 |
| 87 | MP0003795_abnormal_bone_structure | 0.71867230 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.71526129 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.69275529 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.68248299 |
| 91 | MP0002254_reproductive_system_inflammat | 0.67189121 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.65004963 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63833882 |
| 94 | MP0008874_decreased_physiological_sensi | 0.62225145 |
| 95 | MP0004130_abnormal_muscle_cell | 0.62190441 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 0.60878990 |
| 97 | * MP0002136_abnormal_kidney_physiology | 0.58045326 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.57205564 |
| 99 | MP0005451_abnormal_body_composition | 0.56632072 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.56559282 |
| 101 | MP0003091_abnormal_cell_migration | 0.56283072 |
| 102 | MP0001663_abnormal_digestive_system | 0.55810813 |
| 103 | MP0003763_abnormal_thymus_physiology | 0.55804306 |
| 104 | MP0009115_abnormal_fat_cell | 0.55705312 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.55427269 |
| 106 | MP0000609_abnormal_liver_physiology | 0.54385199 |
| 107 | MP0005388_respiratory_system_phenotype | 0.54044655 |
| 108 | MP0002133_abnormal_respiratory_system | 0.54044655 |
| 109 | MP0005365_abnormal_bile_salt | 0.53982658 |
| 110 | MP0000490_abnormal_crypts_of | 0.53784023 |
| 111 | MP0008873_increased_physiological_sensi | 0.52575083 |
| 112 | MP0001873_stomach_inflammation | 0.52276357 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 0.52247719 |
| 114 | MP0000920_abnormal_myelination | 0.52170275 |
| 115 | MP0001958_emphysema | 0.49254779 |
| 116 | MP0005023_abnormal_wound_healing | 0.49102849 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.47096138 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.46145740 |
| 119 | MP0004858_abnormal_nervous_system | 0.43453001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Recurrent abscess formation (HP:0002722) | 8.13640981 |
| 2 | * Recurrent bacterial skin infections (HP:0005406) | 7.15587380 |
| 3 | * Eczematoid dermatitis (HP:0000976) | 6.75441146 |
| 4 | * Recurrent gram-negative bacterial infections (HP:0005420) | 6.41022317 |
| 5 | * Abnormality of macrophages (HP:0004311) | 5.08357412 |
| 6 | * Mediastinal lymphadenopathy (HP:0100721) | 5.00785066 |
| 7 | Stomatitis (HP:0010280) | 4.77195707 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.69884325 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.55926284 |
| 10 | * Recurrent skin infections (HP:0001581) | 4.39304471 |
| 11 | * Gingivitis (HP:0000230) | 4.34311918 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 4.20735043 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 4.17548769 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.09039324 |
| 15 | Myositis (HP:0100614) | 4.02509228 |
| 16 | * Obstructive lung disease (HP:0006536) | 3.99597187 |
| 17 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.99597187 |
| 18 | Orchitis (HP:0100796) | 3.92292750 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.91616122 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.77039576 |
| 21 | Optic neuritis (HP:0100653) | 3.77039576 |
| 22 | * Recurrent fungal infections (HP:0002841) | 3.71210610 |
| 23 | Prostate neoplasm (HP:0100787) | 3.62625552 |
| 24 | Vasculitis (HP:0002633) | 3.59496348 |
| 25 | Disinhibition (HP:0000734) | 3.57469578 |
| 26 | Periodontitis (HP:0000704) | 3.43163408 |
| 27 | Pustule (HP:0200039) | 3.39632713 |
| 28 | Axonal loss (HP:0003447) | 3.29027322 |
| 29 | Glomerulonephritis (HP:0000099) | 3.25163313 |
| 30 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.20952403 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.20652843 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.20652843 |
| 33 | Basal ganglia calcification (HP:0002135) | 3.19054265 |
| 34 | T lymphocytopenia (HP:0005403) | 3.18796367 |
| 35 | Amyloidosis (HP:0011034) | 3.09716874 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 3.09360371 |
| 37 | Thick nail (HP:0001805) | 3.08498433 |
| 38 | * Cellulitis (HP:0100658) | 3.08052847 |
| 39 | Dysostosis multiplex (HP:0000943) | 3.00926362 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.97586503 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.97586503 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.97586503 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.95651394 |
| 44 | * Recurrent viral infections (HP:0004429) | 2.88305691 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.84689647 |
| 46 | * Meningitis (HP:0001287) | 2.84041992 |
| 47 | * Urticaria (HP:0001025) | 2.83186284 |
| 48 | Increased IgM level (HP:0003496) | 2.78399919 |
| 49 | Encephalitis (HP:0002383) | 2.77919263 |
| 50 | Agnosia (HP:0010524) | 2.76622470 |
| 51 | Myocardial infarction (HP:0001658) | 2.66675390 |
| 52 | Leukocytosis (HP:0001974) | 2.53188725 |
| 53 | Tetraparesis (HP:0002273) | 2.52809524 |
| 54 | Mutism (HP:0002300) | 2.50826296 |
| 55 | Chest pain (HP:0100749) | 2.49059706 |
| 56 | * Recurrent pneumonia (HP:0006532) | 2.48712920 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.47130957 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.46330548 |
| 59 | Prolonged bleeding time (HP:0003010) | 2.43837875 |
| 60 | * Osteomyelitis (HP:0002754) | 2.41443069 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.40805647 |
| 62 | Hemoptysis (HP:0002105) | 2.39070684 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.37233945 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.37233945 |
| 65 | Chronic otitis media (HP:0000389) | 2.36021855 |
| 66 | Joint hemorrhage (HP:0005261) | 2.35972719 |
| 67 | Nephritis (HP:0000123) | 2.34208989 |
| 68 | Gingival bleeding (HP:0000225) | 2.33865541 |
| 69 | Arterial thrombosis (HP:0004420) | 2.33781558 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.33256470 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.32519294 |
| 72 | Hematochezia (HP:0002573) | 2.29968006 |
| 73 | Pulmonary embolism (HP:0002204) | 2.29652382 |
| 74 | Increased serum ferritin (HP:0003281) | 2.27583903 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.26694542 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.26478224 |
| 77 | Abnormality of the prostate (HP:0008775) | 2.25729509 |
| 78 | * Recurrent lower respiratory tract infections (HP:0002783) | 2.24139790 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.22489980 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.22489980 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.22489980 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.19146033 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.19146033 |
| 84 | Petechiae (HP:0000967) | 2.18561980 |
| 85 | Premature loss of primary teeth (HP:0006323) | 2.17936088 |
| 86 | Neuronal loss in central nervous system (HP:0002529) | 2.17106971 |
| 87 | Increased IgE level (HP:0003212) | 2.15142966 |
| 88 | Loss of speech (HP:0002371) | 2.14980895 |
| 89 | Polyneuropathy (HP:0001271) | 2.13739630 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.12736161 |
| 91 | Colitis (HP:0002583) | 2.11136517 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10652029 |
| 93 | Abnormality of T cells (HP:0002843) | 2.09609566 |
| 94 | Episodic fever (HP:0001954) | 2.08393301 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 2.05359926 |
| 96 | Pathologic fracture (HP:0002756) | 2.04563551 |
| 97 | Amaurosis fugax (HP:0100576) | 2.04413239 |
| 98 | Poor head control (HP:0002421) | 2.04385143 |
| 99 | Gangrene (HP:0100758) | 2.04301012 |
| 100 | Vertigo (HP:0002321) | 2.02000642 |
| 101 | Abnormality of iron homeostasis (HP:0011031) | 2.00888032 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.00861632 |
| 103 | Progressive visual loss (HP:0000529) | 1.99367207 |
| 104 | Abnormality of the periventricular white matter (HP:0002518) | 1.99350362 |
| 105 | Bone pain (HP:0002653) | 1.99153421 |
| 106 | Malnutrition (HP:0004395) | 1.95620786 |
| 107 | Glomerulopathy (HP:0100820) | 1.94996447 |
| 108 | Global brain atrophy (HP:0002283) | 1.94161926 |
| 109 | Cheilitis (HP:0100825) | 1.93780402 |
| 110 | * Skin ulcer (HP:0200042) | 1.93753185 |
| 111 | Abnormality of the endocardium (HP:0004306) | 1.93661000 |
| 112 | Abnormality of the pleura (HP:0002103) | 1.92586542 |
| 113 | Eosinophilia (HP:0001880) | 1.91425315 |
| 114 | * Sepsis (HP:0100806) | 1.91363533 |
| 115 | Anorexia (HP:0002039) | 1.91162942 |
| 116 | Arthralgia (HP:0002829) | 1.90438906 |
| 117 | Progressive neurologic deterioration (HP:0002344) | 1.89964249 |
| 118 | Abnormality of complement system (HP:0005339) | 1.89289396 |
| 119 | Increased CSF protein (HP:0002922) | 1.86338236 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.85367748 |
| 121 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.84795771 |
| 122 | Gastrointestinal inflammation (HP:0004386) | 1.84678101 |
| 123 | Diminished motivation (HP:0000745) | 1.84518417 |
| 124 | Restrictive lung disease (HP:0002091) | 1.84516993 |
| 125 | Upper motor neuron abnormality (HP:0002127) | 1.84327458 |
| 126 | Epistaxis (HP:0000421) | 1.83482960 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.83044203 |
| 128 | Purpura (HP:0000979) | 1.82563056 |
| 129 | Peritonitis (HP:0002586) | 1.81968807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.14980815 |
| 2 | BLK | 4.42312518 |
| 3 | MAP3K14 | 4.05285411 |
| 4 | PBK | 3.80401310 |
| 5 | IRAK4 | 3.79564976 |
| 6 | TBK1 | 3.11009466 |
| 7 | IRAK3 | 2.95934540 |
| 8 | TYK2 | 2.92014133 |
| 9 | MAP4K1 | 2.84568619 |
| 10 | PRPF4B | 2.59368762 |
| 11 | IKBKE | 2.49479465 |
| 12 | JAK3 | 2.15530156 |
| 13 | IKBKB | 2.06733078 |
| 14 | TXK | 2.04276867 |
| 15 | KIT | 1.99307115 |
| 16 | ERN1 | 1.99292043 |
| 17 | CSK | 1.89961303 |
| 18 | JAK1 | 1.88129821 |
| 19 | FGR | 1.73225735 |
| 20 | MAP3K13 | 1.58406061 |
| 21 | PIM2 | 1.56133948 |
| 22 | SYK | 1.50189156 |
| 23 | HCK | 1.45503413 |
| 24 | TAOK3 | 1.43901777 |
| 25 | CSF1R | 1.42650011 |
| 26 | ZAP70 | 1.36274581 |
| 27 | LYN | 1.32591008 |
| 28 | CAMKK2 | 1.31701748 |
| 29 | BTK | 1.30855833 |
| 30 | MARK3 | 1.23867528 |
| 31 | TAOK1 | 1.20974575 |
| 32 | FES | 1.16329231 |
| 33 | NEK9 | 1.14229248 |
| 34 | CLK1 | 1.14140483 |
| 35 | TNK2 | 1.12963675 |
| 36 | MATK | 1.12891065 |
| 37 | EPHB1 | 1.12691800 |
| 38 | STK10 | 1.12344578 |
| 39 | LCK | 1.11566617 |
| 40 | BMPR2 | 1.10683087 |
| 41 | CHUK | 1.09274361 |
| 42 | PIM1 | 1.08945733 |
| 43 | JAK2 | 1.07480286 |
| 44 | NME2 | 1.07441864 |
| 45 | BMX | 1.06487137 |
| 46 | MST1R | 1.06384717 |
| 47 | ABL2 | 1.05885609 |
| 48 | STK4 | 1.04812285 |
| 49 | ACVR1B | 1.00359395 |
| 50 | TEC | 1.00253099 |
| 51 | MST4 | 0.97684610 |
| 52 | RPS6KA4 | 0.96031738 |
| 53 | YES1 | 0.91506445 |
| 54 | PIK3CG | 0.91410256 |
| 55 | TAOK2 | 0.88667991 |
| 56 | MAP3K2 | 0.86778688 |
| 57 | CDC42BPA | 0.84618903 |
| 58 | TRPM7 | 0.84251470 |
| 59 | PRKCD | 0.79612745 |
| 60 | MAP3K6 | 0.79278652 |
| 61 | FGFR3 | 0.77674042 |
| 62 | EGFR | 0.74659120 |
| 63 | TGFBR2 | 0.73424888 |
| 64 | MAP3K5 | 0.72793663 |
| 65 | MARK2 | 0.71308631 |
| 66 | MAPK12 | 0.70208743 |
| 67 | EIF2AK2 | 0.69347059 |
| 68 | SGK3 | 0.69119516 |
| 69 | MAP2K3 | 0.68735045 |
| 70 | ABL1 | 0.68712709 |
| 71 | ERBB3 | 0.68187495 |
| 72 | MAPK7 | 0.67344648 |
| 73 | RIPK1 | 0.66600181 |
| 74 | GRK7 | 0.66550184 |
| 75 | FGFR4 | 0.66023425 |
| 76 | LRRK2 | 0.58791793 |
| 77 | TTN | 0.56838942 |
| 78 | MAP3K11 | 0.55103343 |
| 79 | SGK2 | 0.53659256 |
| 80 | GRK6 | 0.53500575 |
| 81 | TESK1 | 0.52020005 |
| 82 | SIK3 | 0.51986992 |
| 83 | CAMK1D | 0.51886930 |
| 84 | IRAK1 | 0.51860157 |
| 85 | CAMKK1 | 0.51310770 |
| 86 | PDK2 | 0.51253819 |
| 87 | SIK2 | 0.50234153 |
| 88 | IRAK2 | 0.48430809 |
| 89 | KSR1 | 0.47529487 |
| 90 | TESK2 | 0.45917442 |
| 91 | EPHA3 | 0.45675016 |
| 92 | FYN | 0.45249303 |
| 93 | PRKCQ | 0.45055101 |
| 94 | ITK | 0.44267355 |
| 95 | RPS6KA6 | 0.43281417 |
| 96 | TRIB3 | 0.39867162 |
| 97 | ARAF | 0.39145307 |
| 98 | PDPK1 | 0.38955706 |
| 99 | MAP3K10 | 0.38107220 |
| 100 | CAMK1G | 0.37560384 |
| 101 | MAP2K4 | 0.37318111 |
| 102 | PDK1 | 0.36775523 |
| 103 | RPS6KA2 | 0.36467629 |
| 104 | RAF1 | 0.35269164 |
| 105 | RET | 0.35231113 |
| 106 | CAMK4 | 0.34154426 |
| 107 | CDK6 | 0.34063420 |
| 108 | DDR2 | 0.33921759 |
| 109 | STK3 | 0.33489378 |
| 110 | RPS6KL1 | 0.32605220 |
| 111 | RPS6KC1 | 0.32605220 |
| 112 | DAPK2 | 0.31808993 |
| 113 | MAP3K12 | 0.30815261 |
| 114 | MAPKAPK2 | 0.30174985 |
| 115 | MAP3K1 | 0.29778407 |
| 116 | DAPK3 | 0.29398742 |
| 117 | MOS | 0.27213025 |
| 118 | IGF1R | 0.26629595 |
| 119 | MAP3K3 | 0.25873670 |
| 120 | ADRBK2 | 0.25730209 |
| 121 | PTK6 | 0.25222920 |
| 122 | KSR2 | 0.25178418 |
| 123 | MAPK4 | 0.25143267 |
| 124 | PRKCH | 0.18951143 |
| 125 | ALK | 0.18786932 |
| 126 | INSR | 0.18251332 |
| 127 | PDGFRB | 0.17869641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.81275964 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.76004645 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.91249994 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90956752 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.70354051 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.58580948 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53977919 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.50076068 |
| 9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44868581 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.35184290 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.30817384 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30189658 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22314838 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.10777942 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.09961860 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09547631 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 2.04027949 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.98482381 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94012757 |
| 20 | * Phagosome_Homo sapiens_hsa04145 | 1.92075439 |
| 21 | Salmonella infection_Homo sapiens_hsa05132 | 1.87722427 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.81529350 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.80804498 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80583114 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78596245 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62443075 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62429902 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.56403097 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53369524 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.52756442 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52291576 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48800299 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48236847 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48024447 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45162333 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44041806 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.31451305 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31319742 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28011115 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.27589834 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15151876 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.06430442 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05976237 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05931740 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03251074 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.01701317 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.01100212 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00671971 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00349509 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.98370434 |
| 51 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94166749 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86832857 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86684109 |
| 54 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77965437 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77803993 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71585339 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69896127 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.69621649 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69095329 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.67823693 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66595664 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64703118 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61407165 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.59622046 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58062879 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55775753 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55693744 |
| 68 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54082002 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54071021 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52190914 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51286696 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50687535 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49108705 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48338782 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45825916 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44587896 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42270419 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39635480 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39145805 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38923196 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38027441 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37637645 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.36789009 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35585991 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.35408303 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34877642 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34734189 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33110976 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32546289 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32520032 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.31031000 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30855905 |
| 93 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29737024 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29251127 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28290747 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27593758 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26376611 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25919102 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.25844776 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25297023 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.25204490 |
| 102 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23818697 |
| 103 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22007046 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17158840 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16875615 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16873345 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15661433 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15176042 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.14661689 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.14120063 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06702018 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.05720179 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.05299987 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04816732 |

